Mechanisms for HIV persistence during effective treatment

dc.contributor.advisorFrenkel, Lisa M
dc.contributor.authorAamer, Hadega
dc.date.accessioned2020-04-30T17:39:48Z
dc.date.issued2020-04-30
dc.date.submitted2020
dc.descriptionThesis (Ph.D.)--University of Washington, 2020
dc.description.abstractDespite antiretroviral therapy (ART) that suppresses HIV replication to below the limit-of-quantification of commercial assays, small numbers of virions can often still be detected in the plasma, termed residual viremia (RV). The cells producing infectious RV must be eliminated to cure the infection. The dynamics of RV production was characterized by determining viral C2V5env sequences from longitudinally-derived plasma specimens, comparing RV sequences to those from replicating viruses in pre-ART plasma, in quantitative viral outgrowth assays (QVOA) of virus present in CD4+ T cells collected during ART, and in plasma from post-ART-interruption. Specimens from the time of acute infection and spanning more than 13 years of infection were examined from 3 participants in which ART was initiated after ~3 or more years of infection. Following ART-suppression for ~7 years, participants self-initiated ART-interruptions. RV was found to be composed of varying fractions (8-84%) of monotypic (i.e., clonally-derived) versus unique HIV genotypes that were most closely related to viruses produced throughout the pre-ART period, and these monotypic RV variants persisted for a median of 3 years (range:0.3-8.2) of ART-suppression. RV sequences were found to be identical to replicating viruses found during pre-ART and infectious variants induced in QVOA and rebound viremia (n=21/154 (14%)) across the 3 participants. The frequency of RV variants during ART was not always predictive of the composition to rebound viremia after ART-interruption. These findings are consistent with a dynamic “active” HIV reservoir during ART that can contribute to the rekindling of infection upon ART interruption. The persistence of monotypic RV variants over time suggests that the cells producing these virions either resist immune clearance or represent the occasional emergence from latency of only subpopulations of clonally proliferating, infected cell populations, which are only slowly cleared over time.
dc.embargo.lift2021-04-30T17:39:48Z
dc.embargo.termsRestrict to UW for 1 year -- then make Open Access
dc.format.mimetypeapplication/pdf
dc.identifier.otherAamer_washington_0250E_21200.pdf
dc.identifier.urihttp://hdl.handle.net/1773/45410
dc.language.isoen_US
dc.rightsnone
dc.subjectHIV
dc.subjectinfectious
dc.subjectplasma
dc.subjectrebound virus
dc.subjectreservoir
dc.subjectresidual viremia
dc.subjectVirology
dc.subjectMolecular biology
dc.subject.otherGlobal Health
dc.titleMechanisms for HIV persistence during effective treatment
dc.typeThesis

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Aamer_washington_0250E_21200.pdf
Size:
2.08 MB
Format:
Adobe Portable Document Format

Collections